Eqis Capital Management, Inc. Anika Therapeutics, Inc. Transaction History

Eqis Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$27.83 - $37.73 $207,834 - $281,767	-7,468 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$22.38 - $54.06 $43,506 - $105,092	1,944 Added 35.19%	7,468 $309,000
Q4 2019 Jan 24, 2020	SELL	$51.85 - $73.36 $65,642 - $92,873	-1,266 Reduced 18.65%	5,524 $286,000
Q3 2019 Nov 05, 2019	SELL	$40.05 - $57.47 $137,411 - $197,179	-3,431 Reduced 33.57%	6,790 $373,000
Q2 2019 Jul 18, 2019	BUY	$30.3 - $41.14 $309,696 - $420,491	10,221 New	10,221 $415,000
Q2 2018 Jul 27, 2018	SELL	$28.77 - $48.27 $1.05 Million - $1.76 Million	-36,393 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$49.22 - $68.43 $4,380 - $6,090	89 Added 0.25%	36,393 $1.81 Million
Q4 2017 Jan 25, 2018	SELL	$52.14 - $59.94 $263,411 - $302,816	-5,052 Reduced 12.22%	36,304 $1.96 Million
Q3 2017 Oct 03, 2017	BUY	$51.16 - $58.21 $2.12 Million - $2.41 Million	41,356	41,356 $2.4 Million

118

11.8M

2.7K

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $358M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.